INDIVIDUAL VARIATION IN RENAL DOSIMETRY OF Lu-177 OCTREOTATE

被引：0
作者：
McKay, Erin [1 ]
机构：
[1] St George Hosp, Sydney, NSW, Australia
来源：
INTERNAL MEDICINE JOURNAL | 2013年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：8 / 8
页数：1
相关论文
共 50 条
  • [41] Dynamic Cell Dosimetry Model for in Vitro Cell Assays with 177Lu-DOTA Octreotate
    Konijnenberg, M. W.
    Verwijnen, S.
    de Jong, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S101 - S101
  • [42] Dynamic Tumour Dosimetry Model for Peptide Radionuclide Therapy with 177Lu-DOTA-Octreotate
    Konijnenberg, M. W.
    Bernard, B. F.
    De Jong, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S101 - S101
  • [43] Peptide receptor radionuclide therapy using somatostatin receptor antagonists: first results of biodistribution and dosimetry of Lu-177 DOTA-LM3 compared to Lu-177 DOTATOC
    Schuchardt, Christiane
    Kulkarni, Harshad
    Singh, Aviral
    Mueller, Dirk
    Fani, Melpomeni
    Maecke, Helmut
    Baum, Richard
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [44] High radiotherapeutic efficacy of [Lu-177]-DOTA-Y3-Octreotate in a rat tumor model.
    Erion, JL
    Bugaj, JE
    Schmidt, MA
    Wilhelm, RR
    Srinivasan, A
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (05) : 223P - 223P
  • [45] Prognostic Significance of Somatostatin Receptor Heterogeneity in Progressive Neuroendocrine Tumor Treated with Lu-177 DOTATOC or Lu-177 DOTATATE
    Josephine Graf
    Ulrich-Frank Pape
    Henning Jann
    Timm Denecke
    Ruza Arsenic
    Winfried Brenner
    Marianne Pavel
    Vikas Prasad
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 881 - 894
  • [46] Comparative evaluation of carrier added and non carrier added Lu-177 for preparation of therapeutic doses of Lu-177 radiopharmaceuticals
    Bhusari, P.
    Shukla, J.
    Singh, H.
    Sood, A.
    Mittal, B.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S688 - S688
  • [47] Prognostic Significance of Somatostatin Receptor Heterogeneity in Progressive Neuroendocrine Tumor Treated with Lu-177 DOTATOC or Lu-177 DOTATATE
    Graf, Josephine
    Pape, Ulrich-Frank
    Jann, Henning
    Denecke, Timm
    Arsenic, Ruza
    Brenner, Winfried
    Pavel, Marianne
    Prasad, Vikas
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (04) : 881 - 894
  • [48] Bone marrow dosimetry after [Lu-177-DOTA0, Tyr3]octreotate
    Forrer, Flavio
    Krenning, Eric
    Kooij, Peter
    Konijnenberg, Mark
    Kwekkeboom, Dik
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [49] Establishing a Lu-177 Dotatate Therapy Program
    Snyder, W.
    Harpool, K.
    Swanson, J. W.
    Schantz, P.
    Phan, A.
    Dick, J. S.
    Cavanaugh, S. X.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E499 - E500
  • [50] Size matters: A saga of Lu-177 yield
    Vyas, Madhusudan
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2023, 64
12345